BLZE three-lens brief
Evidence-based stock research on BLZE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 10.51% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.
- Price up 10.51% in the last session — a material single-day move.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 36.5pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $21.50 — 143% above current (6 analysts).
BLZE closed at $8.83 (+10.51%) as of 2026-11-12. Market cap: $558.06M. Price is below the 50-day MA and below the 200-day MA. Positives: price up 10.51% in the last session — a material single-day move.; analyst mean target $21.50 — 143% above current (6 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 36.5pp over 30 days.. Last quarter: Revenue $46.65M, net income -$2.36M, free cash flow $45.44M.
Why three lenses on BLZE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLZE across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BLZE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLZE brief"></iframe>